Is Boule Diagnostics AB stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Boule Diagnostics AB pays dividends. Last time was Thursday 12th of May 2022 where the investors holding the stock on Friday 6th of May 2022 were paid SEK0.38946 per share. Over the last 10 times between 2013 and 2022, Boule Diagnostics AB has paid SEK9.91778 with an average of SEK0.99 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Boule Diagnostics AB 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was SEK39.30, you would have made a loss of SEK-30.44 per share or -77.46%
No, the average daily trading liquidity for Boule Diagnostics AB is SEK19 874 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Boule Diagnostics AB has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.43, the company's ability to pay off the debt is normal. The company has a very low net profit margin of 4.68%, which is challenging.
We have calculated the inflation risk for Boule Diagnostics AB to be low [0.5 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.